東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Haploidentical stem cell transplanta...

Demirer, Taner.

FindBook

Google Book

Amazon

博客來

Haploidentical stem cell transplantation = an emerging treatment modality /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Haploidentical stem cell transplantation/ edited by Taner Demirer.
其他題名:	an emerging treatment modality /
其他作者:	Demirer, Taner.
出版者:	Cham :Springer International Publishing : : 2017.,
面頁冊數:	xv, 199 p. :ill., digital ;24 cm.
內容註:	1. General Indications and Logic for Haploidentical SCT -- 2. Donor Selection and Cell Dose in Haploidentical SCT -- 3. Graft Failure and Rejection in Haploidentical SCT -- 4. Toxicity of Conditioning Regimens in Haploidentical SCT -- 4. Toxicity of Conditioning Regimens in Haploidentical SCT -- 5. An Overview of the Prophylaxis and Treatment of GVHD in Haploidentical STC -- 6. Prevention and Treatment of Infectious Complications in Haploidentical SCT -- 7. Graft versus Leukemia (GVL), Graft versus Lymphoma Effect in Haploidentical SCT -- 8. Outcome of Haploidentical SCT in Patients with Acute Leukemia -- 9. Outcome of Haploidentical SCT in Patients with Lymphoma -- 10. Applications of Haploidentical SCT in Patients with Non-malignant Diseases -- 11. Applications of Haploidentical SCT in Pediatric Patients -- 12. Innovative Approaches in Order to Increase the Success of the Haploidentical SCT. 13. Future Perspectives for Haploidentical SCT.
Contained By:	Springer eBooks
標題:	Hematopoietic stem cells - Transplantation. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-65319-8
ISBN:	9783319653198

Haploidentical stem cell transplantation = an emerging treatment modality /
Haploidentical stem cell transplantationan emerging treatment modality /[electronic resource] :edited by Taner Demirer. - Cham :Springer International Publishing :2017. - xv, 199 p. :ill., digital ;24 cm. - Stem cell biology and regenerative medicine,2196-8985. - Stem cell biology and regenerative medicine..

1. General Indications and Logic for Haploidentical SCT -- 2. Donor Selection and Cell Dose in Haploidentical SCT -- 3. Graft Failure and Rejection in Haploidentical SCT -- 4. Toxicity of Conditioning Regimens in Haploidentical SCT -- 4. Toxicity of Conditioning Regimens in Haploidentical SCT -- 5. An Overview of the Prophylaxis and Treatment of GVHD in Haploidentical STC -- 6. Prevention and Treatment of Infectious Complications in Haploidentical SCT -- 7. Graft versus Leukemia (GVL), Graft versus Lymphoma Effect in Haploidentical SCT -- 8. Outcome of Haploidentical SCT in Patients with Acute Leukemia -- 9. Outcome of Haploidentical SCT in Patients with Lymphoma -- 10. Applications of Haploidentical SCT in Patients with Non-malignant Diseases -- 11. Applications of Haploidentical SCT in Pediatric Patients -- 12. Innovative Approaches in Order to Increase the Success of the Haploidentical SCT. 13. Future Perspectives for Haploidentical SCT.

This book discusses the aspects of haploidentical transplants and will shed light on the debates and questions on this burgeoning field and timely topic. Donor selection, graft failure, minimal CD34+ cell requirement, and conditioning regimens used for haploidentical transplants will be written by expert authors dealing with this type of transplants. Approximately one third of the books' chapters cover logic and basic aspects; the remaining two thirds of the book discuss clinical aspects, outcomes, and future perspectives, thus providing a comphrensive discussion of the topic. Haploidentical transplantation is extremely timely, rapidly-changing area and increasing its use will decrease the need for time-consuming, expensive, unrelated donor search. Moreover, Haploidentical Stem Cell Transplantation brings a set of clear answers to questions of feasibility, advantages over unrelated transplants, cost effectivity and outcome.

ISBN: 9783319653198

Standard No.: 10.1007/978-3-319-65319-8doiSubjects--Topical Terms:

795524
Hematopoietic stem cells
--Transplantation.

LC Class. No.: RD123.5

Dewey Class. No.: 617.44

Haploidentical stem cell transplantation = an emerging treatment modality /
LDR:02961nmm a2200337 a 4500 001 2110682
003 DE-He213
005 20180419144834.0
006 m d
007 cr nn 008maaau
008 180619s2017 gw s 0 eng d
020 $a 9783319653198 $q (electronic bk.)
020 $a 9783319653181 $q (paper)
024 7 $a 10.1007/978-3-319-65319-8 $2 doi
035 $a 978-3-319-65319-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RD123.5
072 7 $a PSAK $2 bicssc
072 7 $a SCI017000 $2 bisacsh
072 7 $a SCI049000 $2 bisacsh
082 0 4 $a 617.44 $2 23
090 $a RD123.5 $b .H252 2017
245 0 0 $a Haploidentical stem cell transplantation $h [electronic resource] : $b an emerging treatment modality / $c edited by Taner Demirer.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana Press, $c 2017.
300 $a xv, 199 p. : $b ill., digital ; $c 24 cm.
490 1 $a Stem cell biology and regenerative medicine, $x 2196-8985
505 0 $a 1. General Indications and Logic for Haploidentical SCT -- 2. Donor Selection and Cell Dose in Haploidentical SCT -- 3. Graft Failure and Rejection in Haploidentical SCT -- 4. Toxicity of Conditioning Regimens in Haploidentical SCT -- 4. Toxicity of Conditioning Regimens in Haploidentical SCT -- 5. An Overview of the Prophylaxis and Treatment of GVHD in Haploidentical STC -- 6. Prevention and Treatment of Infectious Complications in Haploidentical SCT -- 7. Graft versus Leukemia (GVL), Graft versus Lymphoma Effect in Haploidentical SCT -- 8. Outcome of Haploidentical SCT in Patients with Acute Leukemia -- 9. Outcome of Haploidentical SCT in Patients with Lymphoma -- 10. Applications of Haploidentical SCT in Patients with Non-malignant Diseases -- 11. Applications of Haploidentical SCT in Pediatric Patients -- 12. Innovative Approaches in Order to Increase the Success of the Haploidentical SCT. 13. Future Perspectives for Haploidentical SCT.
520 $a This book discusses the aspects of haploidentical transplants and will shed light on the debates and questions on this burgeoning field and timely topic. Donor selection, graft failure, minimal CD34+ cell requirement, and conditioning regimens used for haploidentical transplants will be written by expert authors dealing with this type of transplants. Approximately one third of the books' chapters cover logic and basic aspects; the remaining two thirds of the book discuss clinical aspects, outcomes, and future perspectives, thus providing a comphrensive discussion of the topic. Haploidentical transplantation is extremely timely, rapidly-changing area and increasing its use will decrease the need for time-consuming, expensive, unrelated donor search. Moreover, Haploidentical Stem Cell Transplantation brings a set of clear answers to questions of feasibility, advantages over unrelated transplants, cost effectivity and outcome.
650 0 $a Hematopoietic stem cells $x Transplantation. $3 795524
650 1 4 $a Life Sciences. $3 890838
650 2 4 $a Stem Cells. $3 580755
650 2 4 $a Hematology. $3 808260
650 2 4 $a Oncology. $3 751006
650 2 4 $a Cancer Research. $3 891172
700 1 $a Demirer, Taner. $3 3263983
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Stem cell biology and regenerative medicine. $3 1566296
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-65319-8
950 $a Biomedical and Life Sciences (Springer-11642)